Skip to main content
Congenital disease IgM assay from Bio-Rad gets FDA clearance

Bio-Rad Laboratories' BioPlex 2200 ToRC IgM Assay has been granted clearance by the FDA. The automated and multiplexed panel, which complements the company's BioPlex 2200 ToRC IgG Assay, is designed for detecting IgM class antibodies to congenital disease-associated pathogens, including Toxoplasma gondii, rubella and cytomegalovirus.

Full Story: